National Brain Tumor Society Provides Funding to Expand the Potential of a Promising Therapeutic in Development for Glioblastoma
$100,000 grant will support researchers at Cleveland Clinic and Curtana Pharmaceuticals investigating the possible dual action of a novel small molecule drug National Brain Tumor Society (NBTS), a leader in brain tumor patient advocacy, research, information, and support, today announced that it’s providing $100,000 to support research on the novel drug candidate, CT-179, which is […]
May 20, 2020